Litcius/Paper detail

Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast?

Eleonora Lai, Giorgio Astara, Pina Ziranu, Andrea Pretta, Marco Migliari, Marco Dubois, Clelia Donisi, Stefano Mariani, Nicole Liscia, Valentino Impera, Mara Persano, S. Tolu, Francesca Balconi, Giovanna Pinna, Dario Spanu, Annagrazia Pireddu, Giorgio Saba, Silvia Camera, Francesca Musio, Marco Puzzoni, Valeria Pusceddu, Clelia Madeddu, Andrea Casadei‐Gardini, Mario Scartozzi

2020Critical Reviews in Oncology/Hematology42 citationsDOI

Topics & Concepts

ImmunotherapyOncolytic virusMedicineHepatocellular carcinomaTumor microenvironmentClinical trialCancerOncologyCancer immunotherapyMonoclonal antibodyImmunologyCancer researchImmune systemInternal medicineAntibodyHepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? | Litcius